Prescription attached:-
Clinical Prescription Review & Final Working Diagnostic Assessment
ENT — Nasal Obstruction with Gross Left-sided Deviated Nasal Septum (DNS) and Bilateral Inferior Turbinate Hypertrophy (ITH)
বাংলা শিরোনাম: বাম দিকে উল্লেখযোগ্যভাবে বাঁকা নাকের সেপ্টাম এবং উভয় পাশের Inferior Turbinate বড় হয়ে যাওয়ার সঙ্গে নাক বন্ধ থাকার সমস্যা।
Prescription date / প্রেসক্রিপশনের তারিখ: 08 October 2026
Review date / পর্যালোচনার তারিখ: Saturday, 24 October 2026
Review time / সময় (Bangladesh Standard Time): 10:44 AM (UTC+06:00)
Hospital / হাসপাতাল: The ENT & Head-Neck Cancer Hospital & Institute, Dhaka
Patient age / রোগীর বয়স: 37 years
Specialty / বিভাগ: ENT (Otorhinolaryngology — কান, নাক ও গলা)
Author / লেখক: Md. Rafiqul Islam Lipu
Proposed publication identifiers — NOT published or reserved: TC(1421).(12). ENT Department Case No (98)
- TC / Total Case serial: proposed 1421. The latest indexed site entry located during this review was TC(1420), dated 21 October 2026.
- DCS / department code: 12 (the site’s code used for ENT; the site does not clearly define the expansion “DCS” in the records found).
- Department Case No: proposed ENT Case No. 98; the latest indexed ENT case number located was 97.
- Important: These are suggested identifiers only, not a confirmed reservation. The site blog endpoint timed out during checking, so a newer post not yet indexed by search may exist. Verify the live site before publication. Confidence: 0.84 for suggested sequence; not a guarantee of uniqueness.
Scope and safety note / সীমা ও নিরাপত্তা: This is a retrospective, educational review of the provided prescription text—not a fresh examination of the patient. Documented prescription findings are separated from clinical inference. A prescription demo below reproduces the reported orders for review; it is not an independently validated instruction to start, increase, stop, or change medicine. Confirm doses and surgery decisions with the treating ENT surgeon and anaesthetist.
1. Case Identity & Source Details — কেস পরিচিতি ও তথ্যের উৎস
Documented facts / নথিতে সরাসরি উল্লেখিত তথ্য
- Age: 37 years.
- Main symptom: Nasal obstruction (নাক বন্ধ থাকা / নাক দিয়ে শ্বাস নিতে অসুবিধা).
- Examination note: “Gross DNS to LT” and “Bil. HIT”.
- Prescribed medicines: Bilfast Kids 10 mg and Momeson 50 mcg/actuation nasal spray.
- Planned procedure: “Septoplasty with SMD under G/A”.
- Separate formal diagnosis line: not documented in the source text.
Not documented / নথিতে উল্লেখ নেই: patient name, sex, duration and side-severity of obstruction, allergy history, previous medical treatment and response, trauma history, comorbidities, drug allergies, pregnancy/lactation status, vital signs, nasal endoscopy report, and investigation results. No investigation result is supplied, so results must not be inferred from tests being ordered.
Clinical interpretation / ক্লিনিক্যাল ব্যাখ্যা: The examination phrases and planned operation strongly support a structural nasal obstruction assessment involving DNS and inferior turbinate hypertrophy. Confidence: 0.96 that these findings were documented; 0.90 that they form the intended working diagnosis, based on the recorded examination and planned surgery.
2. C/C — Chief Complaint (প্রধান অভিযোগ)
Documented C/C: Nasal Obstruction — নাক বন্ধ থাকা বা নাক দিয়ে স্বাভাবিকভাবে বাতাস চলাচলে বাধা।
Clinical meaning / ক্লিনিক্যাল অর্থ: Nasal obstruction is a symptom, not by itself a final diagnosis. It may result from structural narrowing (e.g., deviated septum), mucosal swelling (e.g., rhinitis), nasal polyps, nasal-valve problems, or other lesions.
History still required / আরও যে ইতিহাস নিতে হবে: duration; continuous versus intermittent obstruction; one-sided versus both sides; whether symptoms change with posture or season; sneezing, nasal itching, watery discharge, smell loss, facial pain/pressure, nosebleeds, trauma, snoring, witnessed apnoea, and effect on sleep/work. Persistent one-sided obstruction, recurrent unilateral bleeding, an obvious mass, or progressive symptoms require prompt ENT assessment.
Confidence: 1.00 that nasal obstruction is the recorded chief complaint; 0.55 for any specific cause based on C/C alone.
3. Patient History — রোগীর ইতিহাস
Documented history / নথিভুক্ত তথ্য
| Parameter / প্যারামিটার | Source-supported information / নথিতে যা আছে |
|---|---|
| C/C (প্রধান অভিযোগ) | Nasal obstruction |
| Age (বয়স) | 37 years |
| Previous treatment (আগের চিকিৎসা) | Not documented |
| Allergy history (অ্যালার্জির ইতিহাস) | Not documented; antihistamine and S. IgE were ordered, but these do not confirm allergy |
| Trauma / previous nasal surgery (আঘাত/আগের নাকের অপারেশন) | Not documented |
| Comorbidity / regular medicines (সহ-রোগ/নিয়মিত ওষুধ) | Not documented |
| Drug allergy (ওষুধে অ্যালার্জি) | Not documented |
| Sleep-related symptoms (ঘুমের সমস্যা) | Not documented |
| Family/social/occupational triggers (পারিবারিক/সামাজিক/পেশাগত ট্রিগার) | Not documented |
Why this matters / কেন জরুরি: A deviated septum may be visible on examination, but the degree to which it explains symptoms depends on the symptom pattern, nasal examination/endoscopy, other causes of obstruction, and response to suitable medical treatment. An allergy medicine prescription is evidence that allergy may have been considered, not proof that allergic rhinitis is present.
Confidence: 0.99 that the above items are absent from the supplied text; their actual clinical status is unknown.
4. O/E — On Examination (শারীরিক পরীক্ষার ফল)
4.1 “Gross DNS to LT”
Full form: Gross Deviated Nasal Septum to Left.
বাংলা: নাকের মাঝখানের পর্দা/সেপ্টাম উল্লেখযোগ্যভাবে বাম দিকে বাঁকা।
The nasal septum is formed by cartilage and bone and separates the nasal cavity into right and left passages. A marked deviation can narrow airflow on one or both sides. Provisional associated code: ICD-10 J34.2 — Deviated nasal septum.
4.2 “Bil. HIT”
Likely intended meaning: Bilateral hypertrophy of inferior turbinates (উভয় পাশের Inferior Turbinate বড় হয়ে যাওয়া). The abbreviation should be confirmed with the original prescriber if the handwriting or source image is unclear.
Inferior turbinates are normal structures that help warm, humidify, and filter inspired air. Swelling of their mucosa can narrow the nasal airway. Possible contributors include allergic or non-allergic rhinitis, chronic mucosal inflammation, and compensatory enlargement associated with septal deviation. Provisional associated code: ICD-10 J34.3 — Hypertrophy of nasal turbinates.
4.3 What is not documented / যা নথিভুক্ত নয়
No full nasal examination, mucosal appearance, discharge, polyp status, nasal-valve assessment, smell test, or endoscopy findings were provided. Do not write these as normal or abnormal without examination.
Confidence: 0.99 for the recorded DNS finding; 0.94 for interpreting “Bil. HIT” as bilateral inferior turbinate hypertrophy, subject to checking the original notation.
5. Definition, Etiology & Pathophysiology — সংজ্ঞা, কারণ ও রোগের প্রক্রিয়া
Deviated Nasal Septum (DNS) — নাকের সেপ্টাম বাঁকা
Definition / সংজ্ঞা: A structural deviation of the nasal septum from the midline.
Etiology / কারণ: It may be developmental or related to prior nasal trauma; no cause is documented for this patient.
Pathophysiology / রোগের প্রক্রিয়া: Septal deviation narrows part of the nasal passage and may change airflow. It can coexist with turbinate enlargement or rhinitis; the degree of deviation alone does not establish how much obstruction it causes.
Inferior Turbinate Hypertrophy (ITH) — নাকের নিচের টারবিনেট বড় হওয়া
Definition / সংজ্ঞা: Enlargement of the inferior nasal turbinates, often through mucosal swelling and/or tissue enlargement.
Etiology / কারণ: Allergic rhinitis, non-allergic rhinitis, irritant exposure, chronic inflammation, and compensatory enlargement may contribute. In this case the cause is not proven.
Pathophysiology / রোগের প্রক্রিয়া: The enlarged turbinate occupies airway space. Mucosal swelling may improve with appropriate rhinitis treatment, while a fixed structural component may persist.
Allergic Rhinitis (AR) — অ্যালার্জিজনিত নাকের প্রদাহ
Definition / সংজ্ঞা: An IgE-mediated inflammatory disorder of the nasal mucosa following exposure to a relevant allergen in a sensitised person.
Etiology / কারণ: An allergen plus an appropriate sensitisation and symptom history.
Pathophysiology / রোগের প্রক্রিয়া: Allergen exposure activates mast cells and inflammatory mediators, causing symptoms such as sneezing, itching, watery rhinorrhoea, and congestion. AR is not confirmed here because the compatible symptom history and test results are not provided.
Confidence: DNS and turbinate definitions/pathophysiology are established medical concepts (0.98); the cause of this patient’s turbinate hypertrophy and presence of AR remain unconfirmed (0.50).
6. Clinical Features / Symptoms — উপসর্গ ও ক্লিনিক্যাল বৈশিষ্ট্য
Recorded symptom / নথিভুক্ত উপসর্গ: Nasal obstruction only.
Symptoms to ask about / যেসব উপসর্গ জানতে হবে:
- Allergy clues: sneezing bouts, nasal/ocular itching, watery discharge, seasonal or dust-triggered symptoms.
- Sinus disease clues: reduced smell, facial pressure/pain, thick discharge, and symptom duration/course.
- Sleep/functional burden: mouth breathing, snoring, witnessed apnoea, poor sleep, reduced exercise tolerance or quality of life.
- Red flags: persistent one-sided blockage, repeated unilateral bleeding, visible mass, severe or progressive pain, facial swelling, or visual/neurological symptoms.
These are history prompts, not symptoms documented in this patient. Confidence: 1.00 for the single documented symptom; no confidence score can be assigned to undocumented symptoms.
7. Doctor’s Diagnosis vs Working Clinical Diagnosis — চিকিৎসকের নথি ও সম্ভাব্য রোগনির্ণয়
The supplied text contains no separate formal “Dx” line. The clinician’s intended diagnosis is therefore inferred from O/E and surgical planning, not quoted as a formally written diagnosis.
Working assessment / সম্ভাব্য ক্লিনিক্যাল মূল্যায়ন
- Symptomatic gross left-sided deviated nasal septum (DNS) — ICD-10 J34.2. বাংলা: বাম দিকে উল্লেখযোগ্যভাবে বাঁকা সেপ্টাম, যা নাক বন্ধের সমস্যায় ভূমিকা রাখতে পারে. Confidence: 0.95.
- Bilateral inferior turbinate hypertrophy (ITH) — ICD-10 J34.3. বাংলা: নাকের উভয় পাশের নিচের টারবিনেট বড় হওয়া. Confidence: 0.93.
- Nasal obstruction / nasal congestion — ICD-10 R09.81 (symptom code). বাংলা: নাক বন্ধ থাকা. Confidence: 1.00 that the symptom is documented.
- Possible associated allergic rhinitis — not confirmed. বাংলা: অ্যালার্জিজনিত নাকের প্রদাহ থাকতে পারে, তবে বর্তমান তথ্য দিয়ে নিশ্চিত নয়. Do not present J30.9 as an established diagnosis unless clinically supported. Confidence: 0.45 for the possibility only.
Prescription-ready Dx wording / প্রেসক্রিপশনে লেখার উপযোগী Dx
Dx (working): Gross DNS to left (J34.2) + bilateral inferior turbinate hypertrophy (J34.3), with symptomatic nasal obstruction (R09.81). ?Associated allergic rhinitis — history and clinical assessment required; not confirmed.
Important: These codes reflect the documented terms and a symptom code; confirm coding conventions and final diagnosis with the treating clinician. Do not code suspected allergy as confirmed solely because S. IgE was ordered or an antihistamine was prescribed.
8. Investigations — পরীক্ষা-নিরীক্ষা
The following tests were listed in the prescription. Results were not provided.
| No. | Test / সংক্ষিপ্ত রূপ | বাংলা অর্থ | Possible purpose / সম্ভাব্য উদ্দেশ্য | Clinical note |
|---|---|---|---|---|
| 1 | S. IgE | Serum total immunoglobulin E | Allergy may have been considered | Total IgE alone cannot confirm or rule out allergic rhinitis. Interpret with history; allergen-specific IgE or skin-prick testing may be useful when indicated. |
| 2 | CBC | Complete blood count (পূর্ণ রক্ত গণনা) | Haemoglobin, white cells and platelets | Use according to clinical and perioperative context. |
| 3 | BT, CT | Bleeding time, clotting time (রক্তপাত ও জমাট বাঁধার সময়) | Listed as a bleeding assessment | BT/CT are not CT imaging. Routine haemostasis testing is not necessary for every patient; bleeding history and local anaesthetic/surgical protocol matter. |
| 4 | RBS | Random blood sugar (যেকোনো সময়ের রক্তে গ্লুকোজ) | Check glucose | Interpret in clinical context. |
| 5 | S. Creatinine | Serum creatinine (রক্তে ক্রিয়েটিনিন) | Kidney function | eGFR and comorbidities help interpret results. |
| 6 | SGPT / ALT | Alanine aminotransferase | Liver enzyme | Review if relevant to history, medicines and anaesthetic assessment. |
| 7 | TSH | Thyroid-stimulating hormone | Thyroid function | Indication depends on history/symptoms or the clinician’s protocol. |
| 8 | HBsAg | Hepatitis B surface antigen | Hepatitis B screening | Follow local consent, reporting and infection-control policies. |
| 9 | Blood group & Rh | রক্তের গ্রুপ ও Rh factor | Perioperative readiness if required | Need depends on expected blood loss and local protocol. |
| 10 | ECG | Electrocardiogram | Cardiac assessment when indicated | Not routinely necessary for every healthy adult undergoing minor/intermediate surgery; follow risk-based assessment. |
| 11 | 2D Echo | Echocardiography (হৃদ্যন্ত্রের আল্ট্রাসাউন্ড) | Assess cardiac structure/function if indicated | NICE advises against routine resting echo before surgery; consider with relevant murmurs/symptoms, suspected heart failure or other specific indication. |
| 12 | CXR PA | Chest X-ray, postero-anterior view | Chest/lung assessment when indicated | NICE advises against routine preoperative chest X-ray. Use when clinical history/examination provides an indication. |
Interpretation / ব্যাখ্যা: These appear to include a potential allergy assessment and preoperative screening. The need for each test should be individualised by the ENT surgeon and anaesthetist according to history, examination, comorbidities, surgical risk and local protocol. No result may be described as normal or abnormal from this list alone. Confidence: 0.98 that these tests were listed; 0.93 for the guideline-based comments above.
9. Rx Overview — প্রেসক্রিপশনের ওষুধের সারসংক্ষেপ
| No. | Prescribed item | Documented direction | Clinical purpose potentially intended | Main point to review |
|---|---|---|---|---|
| 1 | Bilfast Kids 10 mg dispersible tablet (bilastine) | 0 + 0 + 1, for 1 month | Control of possible allergy symptoms | MedEx monograph lists 10 mg as the usual dose for children 6–11 years; usual dose for adults/adolescents ≥12 years is 20 mg once daily. A 37-year-old’s prescribed dose/strength should be confirmed with the prescriber. Do not self-increase. |
| 2 | Momeson nasal spray 50 mcg/actuation (mometasone furoate) | Recorded as 2 sprays × 2 times daily, both nostrils, for 1 month | Nasal mucosal inflammation, especially if rhinitis contributes | If intended as 2 sprays in each nostril twice daily, total = 8 sprays/day = 400 mcg/day. Confirm intended dose and indication because no polyp diagnosis is documented and dosing differs by indication. |
Clinical distinction / গুরুত্বপূর্ণ পার্থক্য: Neither drug straightens a deviated septum. Intranasal corticosteroids can reduce inflammatory mucosal swelling; antihistamines mainly help histamine-mediated allergy symptoms. Structural obstruction may require a procedure if clinically significant and treatment goals/alternatives have been discussed.
10. Medicine 1 — Bilfast Kids 10 mg (Bilastine): 16-Parameter Review
1. Generic name — জেনেরিক নাম
Bilastine 10 mg dispersible/orally dispersible tablet. বাংলা: বিলাস্টিন ১০ মি.গ্রা. ট্যাবলেট.
2. Brand name — ব্র্যান্ড নাম
Bilfast Kids 10 mg — MedEx lists NIPRO JMI Pharma Ltd. The listed 10 mg formulation is for paediatric dosing. Open Bilfast Kids on MedEx.
3. Alternative MedEx brands/compositions — বিকল্প ব্র্যান্ড ও ফর্ম
MedEx lists bilastine brands including Bilfast 20 mg, Bilista 20 mg, Billi 20 mg, Bilastin 20 mg and multiple others; 10 mg dispersible formulations and oral solutions are also listed. Confirm exact strength and formulation on the current MedEx page before dispensing. All bilastine brands and prices on MedEx.
4. MedEx Therapeutic Class — MedEx-এর থেরাপিউটিক শ্রেণি
Non-sedating antihistamines. বাংলা: সাধারণত কম ঘুমঘুম ভাব সৃষ্টি করা অ্যান্টিহিস্টামিন.
5. Pharmacological class — ফার্মাকোলজিক্যাল শ্রেণি
Second-generation, selective peripheral histamine H1-receptor antagonist. বাংলা: দ্বিতীয় প্রজন্মের H1 হিস্টামিন রিসেপ্টর ব্লকার.
6. Use/purpose — কী কাজে ব্যবহৃত হয়
Allergic rhinoconjunctivitis (seasonal/perennial) and urticaria; it can reduce sneezing, itching, watery nasal discharge, and allergy-related eye symptoms. It is not a structural treatment for DNS.
7. Why prescribed in this patient? — এই রোগীকে কেন দেওয়া হয়ে থাকতে পারে
The prescriber may have been treating a possible allergic component to nasal symptoms. However, the prescription does not document sneezing, itching, rhinorrhoea, a confirmed allergy diagnosis, or S. IgE results. Therefore the patient-specific rationale is plausible but unconfirmed. It will not correct the deviated septum. Confidence: 0.55 for possible intended allergy control; no conclusion that allergy is confirmed.
8. Adverse effects — পার্শ্বপ্রতিক্রিয়া
MedEx monograph describes headache, dizziness and nausea among reported adverse effects; individual response varies. If severe dizziness, facial/lip swelling, breathing difficulty or another serious reaction occurs, seek urgent care.
9. Direct MedEx link — সরাসরি MedEx লিংক
Bilfast Kids 10 mg — MedEx
Bilastine brands — MedEx
10. Unit price, strip/pack price and other compositions — একক/স্ট্রিপ মূল্য ও অন্য ফর্ম
At the time checked, MedEx lists ৳15 per 10 mg tablet; ৳150 per 10-tablet strip; ৳450 for a 30-tablet pack (3 × 10). MedEx also lists 20 mg tablets and 12.5 mg/5 mL oral solution. Prices can change; verify before publication or dispensing. Current MedEx price listing.
11. Mechanism of action — কাজের প্রক্রিয়া
Bilastine selectively blocks peripheral H1 histamine receptors, reducing histamine-mediated itching, sneezing, runny nose and other allergy symptoms. It does not correct cartilage/bone deviation.
12. Indications — ব্যবহারের নির্দেশনা
Allergic rhinoconjunctivitis (seasonal or perennial) and urticaria as listed by MedEx. The clinical indication for this patient must be confirmed from symptoms/history.
13. Interactions and contraindications — ওষুধের পারস্পরিক ক্রিয়া ও নিষেধাজ্ঞা
- Contraindication: known hypersensitivity to bilastine or tablet ingredients.
- MedEx notes that ketoconazole, erythromycin, cyclosporine or diltiazem can increase bilastine concentration; review the complete medicine list.
- Food and fruit juices can reduce bilastine absorption. Follow the product monograph’s empty-stomach instructions and take with water.
- This is not a complete interaction screen; check current product information and the patient’s other drugs.
14. Precautions and warnings — সতর্কতা
Do not use the 10 mg children’s formulation as an adult dose without confirmation. Ask about pregnancy/lactation if relevant, allergies to excipients, and concurrent medicines. Seek clinical review if symptoms persist or worsen. Avoid assuming that an antihistamine alone will relieve fixed structural blockage.
15. Dosage and administration — ডোজ ও সেবনবিধি
Dose written in source: 0 + 0 + 1 (one tablet at night) for one month.
MedEx adult reference dose: adults and adolescents ≥12 years: 20 mg once daily for allergic rhinitis/urticaria; the 10 mg mouth-dispersible formulation is listed for children aged 6–11 years. The prescribed 10 mg in a 37-year-old should be clarified with the prescribing ENT specialist; do not increase or change it independently. MedEx advises taking the adult tablet with water on an empty stomach for optimal exposure (follow exact product directions regarding timing before/after food).
16. Pregnancy and lactation — গর্ভাবস্থা ও স্তন্যদান
The MedEx monograph states information is limited and advises clinician consultation for pregnancy or breastfeeding. Pregnancy and lactation status are not documented in this case; no patient-specific conclusion can be made.
Medicine review confidence: MedEx-listed product/class/price 0.98 at time checked; finding that the dose needs clarification for an adult 0.97; patient-specific allergy indication 0.55.
11. Medicine 2 — Momeson 50 mcg/Actuation Nasal Spray (Mometasone Furoate): 16-Parameter Review
1. Generic name — জেনেরিক নাম
Mometasone furoate 50 micrograms per actuation nasal spray. বাংলা: প্রতি স্প্রেতে মোমেটাসোন ফিউরোয়েট ৫০ মাইক্রোগ্রাম.
2. Brand name — ব্র্যান্ড নাম
Momeson 50 mcg/spray, Incepta Pharmaceuticals Ltd. Open Momeson on MedEx.
3. Alternative MedEx brands/compositions — বিকল্প ব্র্যান্ড ও ফর্ম
For 50 mcg/spray nasal formulations, MedEx lists M-Son, Metamist, Metanase, Metaspray, Momenex, Momespray, Nasomet and Nasonex among other available listings. Check the current pack, manufacturer and price. All mometasone nasal spray brands on MedEx.
4. MedEx Therapeutic Class — MedEx-এর থেরাপিউটিক শ্রেণি
Nasal Steroid Preparations. বাংলা: নাকে ব্যবহারের স্টেরয়েডজাত প্রদাহনাশক ওষুধ.
5. Pharmacological class — ফার্মাকোলজিক্যাল শ্রেণি
Intranasal corticosteroid / glucocorticoid. বাংলা: নাকের ভেতরে স্থানীয়ভাবে কাজ করা কর্টিকোস্টেরয়েড.
6. Use/purpose — কী কাজে ব্যবহৃত হয়
MedEx lists treatment of nasal symptoms of allergic rhinitis and nasal polyps in adults. By reducing mucosal inflammation, it may reduce turbinate mucosal swelling when inflammatory rhinitis contributes. It does not straighten a deviated septum.
7. Why prescribed in this patient? — এই রোগীকে কেন দেওয়া হয়ে থাকতে পারে
The surgeon may have intended to reduce nasal mucosal inflammation/swelling and treat a possible rhinitis component alongside structural DNS/ITH. Allergic rhinitis and polyps are not confirmed in the supplied text. Confidence: 0.70 for the likely anti-inflammatory intent; the exact diagnosis/indication is not documented.
8. Adverse effects — পার্শ্বপ্রতিক্রিয়া
MedEx lists headache, viral infection, pharyngitis, epistaxis (nosebleed) and cough among potential effects. Nasal irritation/dryness can also occur. Rarely, local mucosal injury or septal damage may occur, especially with poor spray technique or prolonged misuse.
9. Direct MedEx link — সরাসরি MedEx লিংক
Momeson 50 mcg/spray — MedEx
Mometasone nasal spray brands — MedEx
10. Unit price, bottle/pack price and other compositions — একক/বোতলের মূল্য ও অন্য ফর্ম
MedEx lists ৳250 for a bottle containing 120 metered sprays. A strip price is not applicable to a nasal spray. At the written direction of eight sprays per day, 120 actuations would last about 15 days; two bottles may be required for a 30-day course, excluding priming/wastage. MedEx lists the nasal spray as 50 mcg/actuation; other mometasone formulations (e.g., topical products or different combinations) must not be substituted for a nasal spray. Current MedEx listing.
11. Mechanism of action — কাজের প্রক্রিয়া
Mometasone activates intracellular glucocorticoid receptors and reduces transcription/release of multiple inflammatory mediators and activity of inflammatory cells. This lowers nasal mucosal inflammation; it does not correct a fixed deviated septum.
12. Indications — ব্যবহারের নির্দেশনা
MedEx lists nasal symptoms of allergic rhinitis and nasal polyps in adults, among product-specific indications. The patient’s record documents DNS/ITH, but does not document nasal polyps or definitively diagnose allergic rhinitis.
13. Interactions and contraindications — পারস্পরিক ক্রিয়া ও নিষেধাজ্ঞা
- Contraindication: hypersensitivity to mometasone or excipients.
- MedEx reports no drug interactions of note for the nasal product; still review the full medication list and the current product monograph.
- Systemic exposure is generally low at labelled nasal doses, but additional corticosteroids or certain strong CYP3A inhibitors may warrant a clinician/pharmacist review depending on the product and context.
14. Precautions and warnings — সতর্কতা
Use caution with active/dormant tuberculosis, untreated fungal/bacterial/systemic viral infection, ocular herpes simplex, recent nasal ulcers, nasal surgery or nasal trauma. Monitor if glaucoma, raised intraocular pressure, cataracts or visual changes are relevant. Aim the nozzle slightly outward, away from the septum, to reduce local trauma. Do not spray into the eyes.
15. Dosage and administration — ডোজ ও ব্যবহারের নিয়ম
Dose recorded: 2 sprays per nostril twice daily for one month (assuming “2 চাপ × 2 বার, উভয় নাকে” means two actuations in each nostril each time). Calculation: 2 sprays × 2 nostrils × 2 administrations/day = 8 actuations/day; 8 × 50 mcg = 400 mcg/day total.
For allergic rhinitis, usual adult dosing commonly starts at 2 sprays per nostril once daily (total 200 mcg/day). Higher dosing may be used for selected indications or inadequate control, and MedEx lists nasal-polyp dosing separately. Since no polyp diagnosis is documented, confirm the intended dose and indication with the prescriber. Do not stop, increase or reduce solely on the basis of this review.
Technique: gently blow the nose; keep the head slightly forward; point the nozzle outward away from the septum; inhale gently while spraying; clean the applicator as directed by the product leaflet.
16. Pregnancy and lactation — গর্ভাবস্থা ও স্তন্যদান
MedEx’s product page contains legacy pregnancy-category wording and notes limited data in pregnancy and uncertainty regarding excretion into breast milk. Current prescribing decisions should use updated product information and a clinician’s assessment of benefit and risk. Pregnancy/lactation status is not documented here.
Medicine review confidence: product/class/price 0.98; calculated 400 mcg/day if the directions were transcribed correctly 0.99; specific indication/dose appropriateness for this patient 0.65 pending prescriber confirmation.
12. Differential Diagnosis — বিকল্প রোগনির্ণয়
| Differential diagnosis / বিকল্প রোগ | Why consider it? / কেন বিবেচনা করা হয় | Current status / বর্তমান অবস্থা |
|---|---|---|
| Allergic rhinitis (অ্যালার্জিজনিত রাইনাইটিস) | Can cause turbinate swelling and nasal congestion; antihistamine/IgE test suggest it may have been considered | Possible, not confirmed; history and test results absent |
| Non-allergic rhinitis (অ্যালার্জি ছাড়া নাকের প্রদাহ) | Irritants, weather, medicines or other mechanisms can cause congestion | Not assessed in supplied record |
| Chronic rhinosinusitis ± nasal polyps (দীর্ঘস্থায়ী রাইনোসাইনুসাইটিস/পলিপ) | May produce persistent blockage, discharge or smell loss | No supporting symptoms/endoscopy documented |
| Nasal valve dysfunction (নাকের প্রবেশপথের ভালভের সমস্যা) | Another structural cause of airflow limitation | Not documented; assess clinically if symptoms suggest it |
| Other unilateral lesion/mass (একপাশের অন্য ক্ষত/মাস) | Important when blockage is persistent/unilateral, bleeding or progressive | No evidence supplied; red flags require ENT assessment |
Most supported assessment: DNS + bilateral inferior turbinate hypertrophy with nasal obstruction. Confidence: 0.93 based on documented examination; all other differentials need history and examination.
13. Surgical Plan & Evidence-Based Treatment — অপারেশনের পরিকল্পনা ও প্রমাণভিত্তিক চিকিৎসা
Recorded plan: “Septoplasty with SMD under G/A”.
- Septoplasty: surgery to correct the deviated nasal septum (বাঁকা সেপ্টাম সংশোধনের অপারেশন).
- SMD — Submucosal Diathermy: a technique intended to reduce inferior turbinate volume from beneath its mucosal surface (টারবিনেটের ভেতরের টিস্যু ছোট করার পদ্ধতি). Confirm the precise technique with the surgeon because local abbreviations can vary.
- G/A — General anaesthesia: the patient is fully unconscious under anaesthetic care (সম্পূর্ণ অজ্ঞান করে অপারেশন).
When surgery may be reasonable / কখন অপারেশন বিবেচ্য
Septoplasty can be considered when clinically important obstruction is attributable to septal deviation, after assessment of other causes and discussion of benefits, risks and alternatives. Turbinate reduction may be considered if enlarged turbinates contribute to obstruction and suitable medical management has not adequately controlled the inflammatory component. Surgery does not cure allergic rhinitis; ongoing rhinitis treatment may still be required.
A multicentre randomised trial in BMJ (2023) found septoplasty improved patient-reported nasal obstruction more than medical management in appropriately selected adults with at least moderate symptoms. This population-level result does not by itself establish the indication for this individual; symptom severity and examination still matter.
Risks to discuss / যে ঝুঁকিগুলো নিয়ে কথা বলা দরকার
Bleeding, infection, crusting, persistent/recurrent obstruction, septal perforation, adhesions, altered nasal shape (uncommon), reduced smell or symptoms that do not improve, and anaesthesia-related risks. The specific risk depends on patient health and procedure. Do not present a generic “1 in 100,000” figure from a prescription as this patient’s personal anaesthesia risk without an anaesthetist’s assessment.
Guideline context: ARIA–EAACI 2024–2025 revision (published in 2025/2026 issue) supports intranasal corticosteroids for allergic rhinitis and conditionally suggests INCS over intranasal antihistamines in relevant patients. NICE NG45 advises against routine preoperative chest X-ray or resting echocardiography for every elective surgery patient; testing should be risk- and indication-based. Confidence: 0.93 for the general evidence summary; patient-specific surgical appropriateness remains 0.70 pending history and direct examination.
14. Commonly Used Bangladesh Options — বাংলাদেশে ব্যবহৃত সম্ভাব্য ওষুধের তালিকা
This is an educational list, not a recommendation to use all medicines together. Select by symptom pattern, age, comorbidities, interactions and response. Prices below are the MedEx-listed prices found during this review and may change. MedEx Therapeutic Class wording is retained as listed.
| No. | Generic / strength | Example Bangladesh brand and MedEx class | Typical clinical role / কেন ব্যবহার হতে পারে | MedEx listed price and link |
|---|---|---|---|---|
| 1 | Bilastine 20 mg | Bilfast 20 mg — Non-sedating antihistamines | Allergy symptoms such as sneezing, itch and watery discharge; not a treatment for structural DNS | ৳15/tablet; ৳150/10-tablet strip. MedEx |
| 2 | Fexofenadine 120 mg | Fexo — Anti-histamine | Seasonal/perennial allergic rhinitis symptoms; generally less sedating than older antihistamines, though effects vary | ৳9/tablet; ৳90/strip. MedEx |
| 3 | Cetirizine 10 mg | Alatrol — Anti-histamine | Sneezing, itching, rhinorrhoea and urticaria; can cause drowsiness in some patients | ৳3.01/tablet; ৳30.10/strip. MedEx |
| 4 | Mometasone furoate 50 mcg/spray | Momeson — Nasal Steroid Preparations | Inflammatory nasal congestion/allergic rhinitis and selected nasal-polyp indications | ৳250/120 metered sprays. MedEx |
| 5 | Fluticasone propionate 50 mcg/spray | Flutispray — MedEx: Fluocinolone & Combined Preparations, Nasal Steroid Preparations | Alternative intranasal corticosteroid for allergic rhinitis; generally choose one nasal steroid, not two together routinely | ৳250/120 metered sprays. MedEx |
| 6 | Azelastine 137 mcg/spray | Azelta — Nasal Anti-histamine preparations | Intranasal antihistamine for selected allergic/vasomotor rhinitis symptoms; may cause bitter taste or drowsiness | ৳180.54/120 metered sprays. MedEx |
| 7 | Azelastine + fluticasone (137 + 50 mcg/spray) | Flonasin — Nasal Steroid Preparations | Combination spray for patients needing both intranasal antihistamine and steroid; not routinely needed with separate overlapping sprays | ৳320/120 metered sprays. MedEx |
| 8 | Sodium chloride 0.9% nasal spray | NaSal / SoloSpray — Nasal Decongestants & Other Nasal Preparations | Helps moisturise and clear mucus; supportive treatment, not a septum-correcting treatment | NaSal: ৳150/200 metered sprays. MedEx brands |
| 9 | Oxymetazoline 0.05% nasal drops | Oxymet — MedEx: Nasal Anti-histamine preparations, Nasal Decongestants & Other Nasal Preparations | Rapid, short-term relief of marked congestion; prolonged use may cause rebound congestion, so generally limit to about 3 days unless specifically directed | ৳50/10 mL. MedEx |
| 10 | Montelukast 10 mg | Montair — Leukotriene receptor antagonists | Consider only in selected patients, especially when another indicated condition such as asthma affects the decision; not first-line for isolated allergic rhinitis | ৳17.50/tablet; ৳175/10-tablet strip. MedEx |
Prescribing principles / প্রেসক্রাইব করার নীতি
- For persistent allergic nasal symptoms, an intranasal corticosteroid is often a mainstay; confirm adherence and spray technique before changing therapy.
- A single oral antihistamine may be useful for itching, sneezing or watery discharge. Avoid duplicating oral antihistamines without a clear reason.
- Do not routinely combine two different intranasal steroids. An antihistamine/steroid combination may be considered for selected patients whose symptoms remain inadequately controlled.
- Oxymetazoline is not a long-term treatment because rebound congestion can develop.
- Montelukast has an important neuropsychiatric warning and is generally not first-line for allergic rhinitis; consider only when a clinician finds the benefit-risk balance appropriate.
- None of these medicines straightens a deviated septum.
Table confidence: 0.94 for the listed MedEx examples/prices on the pages checked; 0.90 for the general roles/cautions. Recheck prices and current product monographs at time of use.
15. Advice, Administration & Monitoring — পরামর্শ, ব্যবহারবিধি ও পর্যবেক্ষণ
Advice recorded in the source / নথিতে লেখা পরামর্শ
- Avoid dust/cold triggers (ধুলাবালি ও উপসর্গ বাড়ায় এমন পরিবেশ এড়িয়ে চলা).
- Do not pick or injure the nose (নাকে খোঁচাখুঁচি না করা).
- Avoid cold foods/drinks (ঠান্ডা খাবার/পানীয় এড়িয়ে চলা) was recorded, but this is not a universal evidence-based requirement for all nasal obstruction; individual triggers can be considered.
- Nasal saline cleansing/irrigation was advised (লবণ-পানি দিয়ে নাক পরিষ্কার). For irrigation, use sterile/distilled water or water that has been boiled and cooled; do not use untreated tap water.
- Surgery-related risks discussed in the source include bleeding, postoperative blockage, septal perforation, nasal shape change and symptoms not fully resolving. These are possible risks, not outcomes that will necessarily occur.
Practical nasal-spray reminders / নাকের স্প্রে ব্যবহারের কৌশল
- Clear the nose gently first.
- Keep the head slightly forward; direct nozzle toward the outer wall of the nostril, away from the septum.
- Inhale gently; do not sniff forcefully into the throat.
- Clean and store the bottle exactly as its leaflet says.
- If recurrent nosebleeds, worsening pain, visual symptoms, severe irritation or no improvement occur, contact the prescriber.
Confidence: 0.92 for the advice transcribed; evidence for cold-food restriction is limited and it is not a standard universal intervention.
16. Prescription Demo, Referral & Follow-up — শিক্ষামূলক প্রেসক্রিপশন নমুনা, রেফারাল ও ফলো-আপ
Educational transcription only — not a new or independently validated patient-specific prescription. Confirm the two medicine directions with the prescribing ENT specialist before issuing/continuing.
Patient: 37 years; name/sex not stated in the supplied record.
C/C: Nasal obstruction.
O/E: Gross DNS to left; bilateral inferior turbinate hypertrophy (interpretation of “Bil. HIT” should be confirmed if source handwriting is unclear).
Working Dx: 1) DNS to left (J34.2); 2) bilateral ITH (J34.3); 3) nasal obstruction (R09.81); ?associated allergic rhinitis, unconfirmed.
Plan documented by original prescriber: Septoplasty with SMD under general anaesthesia.
| Rx item (transcribed) | Original direction in supplied report | Safety/clinical review note |
|---|---|---|
| Bilfast Kids 10 mg (bilastine) | 0 + 0 + 1 for 1 month | Clarify the rationale for the 10 mg paediatric formulation in a 37-year-old; MedEx adult/adolescent reference dose is 20 mg once daily. Do not change without the prescriber. |
| Momeson 50 mcg/spray (mometasone furoate) | 2 sprays × 2 times daily, both nostrils, for 1 month | Verify that this means 2 sprays into each nostril at each of two daily administrations (=400 mcg/day). Confirm intended indication/dose with ENT because polyps are not documented. |
Investigations listed: S. IgE, CBC, BT/CT, RBS, S. creatinine, SGPT/ALT, TSH, HBsAg, blood group/Rh, ECG, 2D echocardiography and CXR PA. Results: not supplied. Investigations should be individualized rather than assumed mandatory for every patient.
Referral — কোন চিকিৎসকের কাছে রেফার করবেন?
- ENT/Otorhinolaryngology specialist (কান-নাক-গলা বিশেষজ্ঞ): confirm septal deviation, turbinate hypertrophy, assess for polyps/other causes, decide on medical treatment versus surgery and clarify medication doses.
- Anaesthesiologist (অ্যানেস্থেসিয়া বিশেষজ্ঞ): preoperative assessment, anaesthesia planning and risk discussion before surgery.
- Allergy/respiratory specialist, when indicated: if a compatible allergy/asthma history is present, symptoms remain difficult to control, or specific allergy testing/management is needed.
Actionable clinical plan / করণীয়
- Reconfirm the original written dose directions and clarify Bilfast Kids 10 mg versus adult bilastine dosing with the prescriber.
- Confirm the intended Momeson dose, indication, technique and planned duration; check response and local adverse effects.
- Obtain symptom duration/severity, allergy features, trauma/surgical history, medication list, comorbidities and red-flag history; perform anterior rhinoscopy and diagnostic nasal endoscopy when indicated.
- Review S. IgE in clinical context; do not diagnose allergic rhinitis from total IgE alone.
- Let the ENT surgeon and anaesthetist individualize preoperative tests using clinical risk and local protocol; routine CXR/echo are not recommended for everyone by NICE NG45.
- Discuss expected benefits, alternatives, surgical risks, recovery, and the possibility that allergic rhinitis may still need treatment after surgery.
Confidence: 0.94 that ENT review and dose clarification are appropriate next steps; no prescription change is authorized by this educational report.
17. Overview / Summary, Actionable Plan & References — সারসংক্ষেপ, করণীয় ও তথ্যসূত্র
Overview / Summary — সারসংক্ষেপ
The most supported working assessment is symptomatic gross left-sided deviated nasal septum (J34.2) with bilateral inferior turbinate hypertrophy (J34.3), causing nasal obstruction (R09.81). Possible allergic rhinitis remains unconfirmed. The planned septoplasty with submucosal diathermy is consistent with the structural findings, but individual surgical suitability depends on direct ENT examination, symptom burden, other causes of obstruction, previous treatment response and informed discussion.
বাংলায় সারাংশ: প্রেসক্রিপশনে সবচেয়ে বেশি সমর্থিত রোগনির্ণয় হলো বাম দিকে উল্লেখযোগ্যভাবে বাঁকা নাকের সেপ্টাম এবং উভয় পাশের Inferior Turbinate বড় হয়ে যাওয়ার কারণে নাক বন্ধ থাকা। সঙ্গে অ্যালার্জিজনিত প্রদাহ থাকতে পারে, কিন্তু বর্তমান নথিতে তা নিশ্চিত নয়।
Highest-priority review points:
- Bilfast Kids 10 mg is a paediatric-strength formulation; confirm dose/strength for a 37-year-old with the prescriber.
- Momeson direction, if interpreted as 2 sprays per nostril twice daily, equals 400 mcg/day; confirm the indication and intended dose.
- S. IgE alone does not confirm allergic rhinitis.
- ECG, echo and CXR decisions should be based on individual preoperative risk and indication, not assumed mandatory for every patient.
Reference List — Textbook, Guideline & DOI
Textbooks
- Dhingra PL, Dhingra S. Diseases of Ear, Nose & Throat and Head & Neck Surgery. 8th ed. Elsevier; 2021. Relevant subjects: nasal septum, turbinate hypertrophy, rhinitis and septoplasty.
- Bailey & Love’s Short Practice of Surgery. 28th ed. CRC Press; 2023. Relevant subject: ENT and nasal surgery.
Guidelines / professional resources 3. Bousquet J, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments. Allergy. 2026;81(4):954–976. DOI: 10.1111/all.70131. Full text: PubMed Central. 4. American Academy of Otolaryngology–Head and Neck Surgery. Clinical Indicators: Septoplasty. 2014. AAO-HNS resource. 5. American Academy of Otolaryngology–Head and Neck Surgery. Clinical Indicators: Inferior Turbinate Surgery. AAO-HNS resource. 6. NICE. Routine Preoperative Tests for Elective Surgery. Guideline NG45; published 5 April 2016. Recommendations. 7. Seidman MD, et al. Clinical Practice Guideline: Allergic Rhinitis. Otolaryngology–Head and Neck Surgery. 2015;152(1 Suppl):S1–S43. DOI: 10.1177/0194599814561600.
Peer-reviewed research 8. Carrie S, et al. Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial. BMJ. 2023;383:e075445. DOI: 10.1136/bmj-2023-075445.
Medicine/price references (MedEx Bangladesh; pages checked for this review) 9. Bilastine brand list and Bilfast Kids 10 mg monograph. 10. Momeson 50 mcg/spray monograph and mometasone nasal brand list. 11. Fexo 120 mg; Alatrol 10 mg; Flutispray 50 mcg/spray; Azelta; Flonasin; sodium chloride nasal products; Oxymet; Montair.
Publication verification source 12. RaiyyanTahsan.com blog index; latest indexed item located during this check: TC(1420) on 21 October 2026. Proposed serial above remains unreserved and should be rechecked at publication time.
Author / লেখক: Md. Rafiqul Islam Lipu
Date / তারিখ: Saturday, 24 October 2026
Time / সময়: 10:44 AM Bangladesh Standard Time (UTC+06:00)
Overall confidence: 0.94 for the source-based documentation review; 0.90 for the working diagnosis based on the supplied prescription; suspected allergic rhinitis remains unconfirmed.